Về Spinchip diagnostics as

Về công ty

SpinChip Diagnostics will market the new state of the art platform for in vitro diagnostics point of care analyses. The technology will provide significant value by enabling faster, easier and more reliable point of care analyses at hospitals and in decentralized medical settings. The fully automated device analyses blood samples within a few minutes. The company will initially focus on the rapid cardiac segment. A Troponin-I analysis is under development and the portfolio will swiftly be broaden to a cardiac panel. The SpinChip platform will deliver the same quality as the very best high-sensitivity central laboratory analyzers, thus making the customer value proposition significantly more attractive than competing point of care platforms.